- Home
- GH vs OSIS Comparison
GH vs OSIS Comparison
Compare GH & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- OSIS
- Stock Information
- Founded
- GH 2011
- OSIS 1987
- Country
- GH United States
- OSIS United States
- Employees
- GH N/A
- OSIS N/A
- Industry
- GH Medical Specialities
- OSIS Industrial Machinery/Components
- Sector
- GH Health Care
- OSIS Technology
- Exchange
- GH Nasdaq
- OSIS Nasdaq
- Market Cap
- GH 4.9B
- OSIS 4.2B
- IPO Year
- GH 2018
- OSIS 1997
- Fundamental
- Price
- GH $98.28
- OSIS $287.84
- Analyst Decision
- GH Strong Buy
- OSIS Strong Buy
- Analyst Count
- GH 22
- OSIS 6
- Target Price
- GH $74.32
- OSIS $260.83
- AVG Volume (30 Days)
- GH 3.4M
- OSIS 169.4K
- Earning Date
- GH 10-29-2025
- OSIS 10-30-2025
- Dividend Yield
- GH N/A
- OSIS N/A
- EPS Growth
- GH N/A
- OSIS 14.72
- EPS
- GH N/A
- OSIS 8.81
- Revenue
- GH $902,569,000.00
- OSIS $1,753,782,000.00
- Revenue This Year
- GH $33.95
- OSIS $8.98
- Revenue Next Year
- GH $25.77
- OSIS $5.46
- P/E Ratio
- GH N/A
- OSIS $32.32
- Revenue Growth
- GH 30.38
- OSIS 9.37
- 52 Week Low
- GH $28.45
- OSIS $149.68
- 52 Week High
- GH $101.57
- OSIS $288.64
- Technical
- Relative Strength Index (RSI)
- GH 77.88
- OSIS 69.85
- Support Level
- GH $88.88
- OSIS $271.47
- Resistance Level
- GH $97.51
- OSIS $288.64
- Average True Range (ATR)
- GH 4.94
- OSIS 9.92
- MACD
- GH 1.89
- OSIS 2.94
- Stochastic Oscillator
- GH 88.05
- OSIS 94.43
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About OSIS OSI Systems Inc. (DE)
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.